104 related articles for article (PubMed ID: 8305197)
1. Enhancement of myocardial damage and alteration of lymphocyte subsets in murine model of postpartum myocarditis.
Yokoyama T; Kanda T; Suzuki T; Murata K
Am J Cardiovasc Pathol; 1993; 4(4):343-51. PubMed ID: 8305197
[TBL] [Abstract][Full Text] [Related]
2. Treatment of virus-induced myocardial injury with a novel immunomodulating agent, vesnarinone. Suppression of natural killer cell activity and tumor necrosis factor-alpha production.
Matsui S; Matsumori A; Matoba Y; Uchida A; Sasayama S
J Clin Invest; 1994 Sep; 94(3):1212-7. PubMed ID: 8083362
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of cyclooxygenase-2 enhances myocardial damage in a mouse model of viral myocarditis.
Takahashi T; Zhu SJ; Sumino H; Saegusa S; Nakahashi T; Iwai K; Morimoto S; Kanda T
Life Sci; 2005 Nov; 78(2):195-204. PubMed ID: 16107267
[TBL] [Abstract][Full Text] [Related]
4. Role of interferon in the protective effect of an immunomodulator derived from the Su strain of Streptococcus pyogenes A3 against viral myocarditis in mice.
Kanda T; Yokoyama T; Suzuki T; Murata K
Arzneimittelforschung; 1993 Jan; 43(1):80-3. PubMed ID: 7680562
[TBL] [Abstract][Full Text] [Related]
5. Combination therapy of OK432 and recombinant human interferon alpha A/D on viral myocarditis in mice starting after infection.
Yokoyama T; Kanda T; Suzuki T; Murata K
J Pharmacol Exp Ther; 1991 Sep; 258(3):1114-9. PubMed ID: 1653836
[TBL] [Abstract][Full Text] [Related]
6. Effect of interleukin-18 on viral myocarditis: enhancement of interferon- gamma and natural killer cell activity.
Kanda T; Tanaka T; Sekiguchi K; Seta Y; Kurimoto M; Wilson McManus JE; Nagai R; Yang D; McManus BM; Kobayashi I
J Mol Cell Cardiol; 2000 Dec; 32(12):2163-71. PubMed ID: 11112992
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of interleukin-6 aggravates viral myocarditis: impaired increase in tumor necrosis factor-alpha.
Tanaka T; Kanda T; McManus BM; Kanai H; Akiyama H; Sekiguchi K; Yokoyama T; Kurabayashi M
J Mol Cell Cardiol; 2001 Sep; 33(9):1627-35. PubMed ID: 11549342
[TBL] [Abstract][Full Text] [Related]
8. Synergistic effects of tacrolimus and human interferon-alpha A/D in murine viral myocarditis.
Kanda T; Nagaoka H; Kaneko K; Wilson JE; McManus BM; Imai S; Suzuki T; Murata K; Kobayashi I
J Pharmacol Exp Ther; 1995 Jul; 274(1):487-93. PubMed ID: 7542339
[TBL] [Abstract][Full Text] [Related]
9. Amiodarone inhibits interleukin 6 production and attenuates myocardial injury induced by viral myocarditis in mice.
Ito H; Ono K; Nishio R; Sasayama S; Matsumori A
Cytokine; 2002 Feb; 17(4):197-202. PubMed ID: 11991672
[TBL] [Abstract][Full Text] [Related]
10. Reduced-energy diet improves survival of obese KKAy mice with viral myocarditis: induction of cardiac adiponectin expression.
Kanda T; Saegusa S; Takahashi T; Sumino H; Morimoto S; Nakahashi T; Iwai K; Matsumoto M
Int J Cardiol; 2007 Jul; 119(3):310-8. PubMed ID: 17275107
[TBL] [Abstract][Full Text] [Related]
11. Nifedipine inhibits the activation of inflammatory and immune reactions in viral myocarditis.
Liu W; Shimada M; Xiao J; Hu D; Matsumori A
Life Sci; 2009 Jul; 85(5-6):235-40. PubMed ID: 19520090
[TBL] [Abstract][Full Text] [Related]
12. Leptin deficiency enhances myocardial necrosis and lethality in a murine model of viral myocarditis.
Kanda T; Takahashi T; Kudo S; Takeda T; Tsugawa H; Takekoshi N
Life Sci; 2004 Aug; 75(12):1435-47. PubMed ID: 15240179
[TBL] [Abstract][Full Text] [Related]
13. CXCL10 inhibits viral replication through recruitment of natural killer cells in coxsackievirus B3-induced myocarditis.
Yuan J; Liu Z; Lim T; Zhang H; He J; Walker E; Shier C; Wang Y; Su Y; Sall A; McManus B; Yang D
Circ Res; 2009 Mar; 104(5):628-38. PubMed ID: 19168435
[TBL] [Abstract][Full Text] [Related]
14. Immunological status and pathology of coxsackie B viral myocarditis and dilated cardiomyopathy.
Chen SX; Mei SW; Bao SH; Zheng XJ; Chang PL; Yao JS; Yao S; Zhang DQ
Chin Med J (Engl); 1993 Sep; 106(9):659-64. PubMed ID: 8287699
[TBL] [Abstract][Full Text] [Related]
15. Embryonic stem cells attenuate viral myocarditis in murine model.
Wang JF; Yang Y; Wang G; Min J; Sullivan MF; Ping P; Xiao YF; Morgan JP
Cell Transplant; 2002; 11(8):753-8. PubMed ID: 12588107
[TBL] [Abstract][Full Text] [Related]
16. Immunoglobulin treatment prevents congestive heart failure in murine encephalomyocarditis viral myocarditis associated with reduction of inflammatory cytokines.
Kishimoto C; Takada H; Kawamata H; Umatake M; Ochiai H
J Pharmacol Exp Ther; 2001 Nov; 299(2):645-51. PubMed ID: 11602677
[TBL] [Abstract][Full Text] [Related]
17. Relevance of inflammatory cell infiltrates for complete atrioventricular block in experimental murine myocarditis.
Kishimoto C; Ohmae M; Tomioka N
Cardiovasc Pathol; 2006; 15(3):139-43. PubMed ID: 16697926
[TBL] [Abstract][Full Text] [Related]
18. Mast cells play a critical role in the pathogenesis of viral myocarditis.
Higuchi H; Hara M; Yamamoto K; Miyamoto T; Kinoshita M; Yamada T; Uchiyama K; Matsumori A
Circulation; 2008 Jul; 118(4):363-72. PubMed ID: 18606918
[TBL] [Abstract][Full Text] [Related]
19. Expression of vascular cell adhesion molecule-1 in murine hearts with acute myocarditis caused by coxsackievirus B3.
Seko Y; Yagita H; Okumura K; Yazaki Y
J Pathol; 1996 Dec; 180(4):450-4. PubMed ID: 9014868
[TBL] [Abstract][Full Text] [Related]
20. CD1d-reactive T-cell activation leads to amelioration of disease caused by diabetogenic encephalomyocarditis virus.
Exley MA; Bigley NJ; Cheng O; Tahir SM; Smiley ST; Carter QL; Stills HF; Grusby MJ; Koezuka Y; Taniguchi M; Balk SP
J Leukoc Biol; 2001 May; 69(5):713-8. PubMed ID: 11358978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
